Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
531 News Items found
Pictured: Gabriela Chiosis
Out of the Lab and into the World: Hsp90 Inhibitor, a New Cancer Drug

A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.
Feature
An illustration
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.
Pictured: Milind Rajadhyaksha, Snehal Patel & Ricardo Toledo-Crow
Out of the Lab and into the World: The Endoscopic Laser Scalpel

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.
Perspective
Pictured: Craig Thompson
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
Pictured: Scott W. Lowe
Biologist Scott Lowe Joins Memorial Sloan Kettering

Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center.
Pictured: Douglas Levine
Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
Pictured: Morgan Huse & Niels Bantilan
Nascent Journeys To Discovery

A glimpse into the minds of three young faculty members: immunologist Morgan Huse, biostatistician Ronglai Shen, and medical oncologist Diane Reidy-Lagunes.
Pictured: Maria Jasin
Studies Provide New Insight into Fundamental Biological Process

Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.
Media Advisory
First Comprehensive Analysis Of Gene Mutations In Ovarian Cancer Brings Patients One Step Closer To Personalized Medicine

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.